Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2015

Feb 13, 2015

34301_dirs_2015-02-13_3c0ee41b-5246-428e-a4a3-d743ce8aad3a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-02-13

Reporting Person: Hawkins Richard J (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-13 Incentive Stock Option (Right to Buy) $0.47 A 25000 Acquired 2025-02-13 Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 41926 Direct

Footnotes

F1: The stock options vest 1/12th each month from date of grant, subject to the terms of the Company's 2014 Equity Incentive Plan.